Building Blocks
This section contains fundamental products for the synthesis of organic and biological compounds. Building blocks are the essential starting materials used to construct complex molecules through various chemical reactions. They play a critical role in drug discovery, material science, and chemical research. At CymitQuimica, we offer a diverse range of high-quality building blocks to support your innovative research and industrial projects, ensuring you have the essential components for successful synthesis.
Subcategories of "Building Blocks"
- Boronic Acids & Boronic Acid Derivatives(5,779 products)
- Chiral Building Blocks(1,238 products)
- Hydrocarbon Building Blocks(6,099 products)
- Organic Building Blocks(60,997 products)
Found 205208 products of "Building Blocks"
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Quinoline-3-carbothioamide
CAS:Quinoline-3-carbothioamide is a synthetic analogue of the natural amino acid L-tryptophan, which is used in the treatment of autoimmune diseases such as nephritis and immunomodulating diseases. Quinoline-3-carbothioamide has been shown to suppress T-cell proliferation in vitro and to inhibit antibody production in mice. The molecular basis for this activity is not known. Quinoline-3-carbothioamide has also been shown to have beneficial effects on renal disease in rats by preventing the development of glomerulonephritis.Formula:C10H8N2SPurity:Min. 95%Molecular weight:188.25 g/mol2-(1-Methyl-1H-1,2,4-triazol-3-yl)ethan-1-amine dihydrochloride
CAS:Versatile small molecule scaffoldFormula:C5H12Cl2N4Purity:Min. 95%Molecular weight:199.08 g/molPyrimidine-5-carboxamidine Hydrochloride
CAS:Versatile small molecule scaffold
Formula:C5H6N4·HClPurity:Min. 95%Molecular weight:122.13 g/mol3-Nitro-4-(propan-2-yl)-1H-pyrrole
CAS:Versatile small molecule scaffoldFormula:C7H10N2O2Purity:Min. 95%Molecular weight:154.17 g/mol1-Hydroxy-1,3-dihydro-2,1-benzoxaborole-7-carbaldehyde
CAS:Versatile small molecule scaffold
Formula:C8H7BO3Purity:Min. 95%Molecular weight:161.95 g/mol1-Hydroxy-1,3-dihydro-2,1-benzoxaborole-6-carbaldehyde
CAS:Versatile small molecule scaffoldFormula:C8H7BO3Purity:Min. 95%Molecular weight:161.95 g/mol2-Azaspiro[5.5]undecan-7-ol
CAS:Versatile small molecule scaffoldFormula:C10H19NOPurity:Min. 95%Molecular weight:169.3 g/mol2-Amino-N-(pyridin-2-yl)ethane-1-sulfonamide hydrochloride
CAS:Versatile small molecule scaffoldFormula:C7H12ClN3O2SPurity:Min. 95%Molecular weight:237.71 g/mol6-Methyl-2-oxo-1,2,5,6,7,8-hexahydro-1,6-naphthyridine-3-carboxylic acid hydrochloride
CAS:Versatile small molecule scaffoldFormula:C10H13ClN2O3Purity:Min. 95%Molecular weight:244.67 g/molMethyl 2-benzyl-1H-imidazole-4-carboxylate
CAS:Versatile small molecule scaffoldFormula:C12H12N2O2Purity:Min. 95%Molecular weight:216.24 g/mol(3-(Benzylamino)oxetan-3-yl)methanol
CAS:Versatile small molecule scaffoldFormula:C11H15NO2Purity:Min. 95%Molecular weight:193.25 g/mol4-(Methylamino)-1,2-dihydropyrimidin-2-one hydrochloride
CAS:Versatile small molecule scaffoldFormula:C5H8ClN3OPurity:Min. 95%Molecular weight:161.59 g/mol7-Bromo-5-chloro-2-methyl-1,3-benzoxazole
CAS:Versatile small molecule scaffoldFormula:C8H5BrClNOPurity:Min. 95%Molecular weight:246.49 g/mol4-Bromo-6-methyl-1-benzofuran
CAS:Versatile small molecule scaffoldFormula:C9H7BrOPurity:Min. 95%Molecular weight:211.05 g/molmethyl 3-amino-2-fluorobenzoate
CAS:Versatile small molecule scaffold
Formula:C8H8FNO2Purity:Min. 95%Molecular weight:169.2 g/mol4-(Pyrrolidin-3-yl)pyridine dihydrochloride
CAS:Versatile small molecule scaffoldFormula:C9H14Cl2N2Purity:Min. 95%Molecular weight:221.12 g/mol2,3-Dihydro-2-[[4-methoxy-3-[2-(3-methylphenyl)ethoxy]benzoyl]amino]-1H-Indene-2-carboxylic Acid
CAS:2,3-Dihydro-2-[[4-methoxy-3-[2-(3-methylphenyl)ethoxy]benzoyl]amino]-1H-Indene-2-carboxylic Acid (MK0893) is a small molecule that belongs to the class of indole carboxamides. It is a potent and selective inhibitor of phosphodiesterase 1 (PDE1), with an IC50 value of less than 10 nM. MK0893 inhibits PDE1 in vitro and in vivo, leading to increased cAMP levels, vasodilation, and induction of nitric oxide synthase. MK0893 has been shown to have therapeutic efficacy in animal models of systemic sclerosis. In these models, MK0893 inhibited the development of skin fibrosis by inhibiting TGFβ signaling, which is implicated in the pathogenesis of systemic sclerosis.Formula:C27H27NO5Purity:Min. 95%Molecular weight:445.51 g/mol[(2S,4S)-4-Fluoro-1-[(2-methyl-1,3-thiazol-4-yl)methyl]pyrrolidin-2-yl]methanamine
CAS:Versatile small molecule scaffoldFormula:C10H16FN3SPurity:Min. 95%Molecular weight:229.32 g/mol2-(1,5-Dimethyl-1H-pyrazol-4-yl)-1-methyl-5-oxopyrrolidine-3-carboxamide
CAS:Versatile small molecule scaffoldFormula:C11H16N4O2Purity:Min. 95%Molecular weight:236.3 g/mol1-Methyl-2-(1-methyl-1H-pyrazol-4-yl)-5-oxopyrrolidine-3-carboxamide
CAS:Versatile small molecule scaffold
Formula:C10H14N4O2Purity:Min. 95%Molecular weight:222.24 g/mol
